Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Childhood Acute Promyelocytic Leukemia With PML-RARA × Arsenic Trioxide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Leukemia, Promyelocytic, Acute 6 Leukemia 2 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Childhood Acute Promyelocytic Leukemia With PML-RARA 1

Interventions

merphos 1 azathiopurine 1 arsenous acid 1 Tretinoin 1 Mitoxantrone 1 Methotrexate 1 Mercaptopurine 1 Idarubicin 1 Cytarabine 1 Arsenic Trioxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00866918 2022-10-25

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia

Children's Oncology Group

Phase 3 Completed

106 enrolled 14 charts

MyeloidOther hematologic neoplasm

Childhood Acute Promyelocytic Leukemia With PML-RARA

Data powered by HemOnc (CC BY 4.0) Colophon ⚡